Hope for smarter lung cancer care
When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows. Medical researchers at Flinders University […]
Call to share all clinical trial results
Development of new or improved anti-cancer treatments are potentially being slowed down by shortfalls in data sharing between pharmaceutical companies and research groups, a new article […]
Chance to lift lung cancer survival
New immunotherapy drugs have transformed the treatment of many cancers but some lung patient patients experience hyperprogression – a paradoxical rapid acceleration of tumour growth – […]
Move over Dr Google – here comes ChatGPT
Public access to sophisticated next-generation AI programs, led by ChatGPT, is opening the way to a new era for patients, carers and even healthcare workers to […]
Innovative health projects receive funding boost
Research to tackle heart conditions, cancer, mental health and vaccines are among 10 successful Flinders University-led projects to be awarded funding in the latest round of […]
Breast cancer medication risk
New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients. Beta-blockers, commonly used to manage cardiovascular […]
Antibiotic overuse reduces bladder cancer survival
The over prescribing of antibiotics is reducing survival rates in patients with urothelial carcinoma and it needs to be stopped to avoid the serious risk posed […]
Funding boost for cancer research
Better drug treatments and diagnoses, and solutions for prostate cancer and multiple myeloma, are among Flinders University research projects funded in this year’s $3 million Beat […]